A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

This trial is conducted in Africa, Asia, Europe, North America and South America. The purpose is to compare long-term glycaemic control of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) in insulin naïve subjects with type 2 diabetes mellitus inadequately controlled with oral anti diabetics.

本试验在非洲、亚洲、欧洲、北美洲及南美洲开展，旨在对比胰岛素初治且口服降糖药控制不佳的2型糖尿病（type 2 diabetes mellitus）患者中，德谷胰岛素利拉鲁肽复方制剂（insulin degludec/liraglutide，IDegLira）与甘精胰岛素（insulin glargine，IGlar）的长期血糖控制效果。